Growth Metrics

Volitionrx (VNRX) Return on Capital Employed (2019 - 2025)

Volitionrx filings provide 8 years of Return on Capital Employed readings, the most recent being 391.29% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 122305.0% to 391.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 391.29%, a 122305.0% increase, with the full-year FY2025 number at 532.76%, up 78105.0% from a year prior.
  • Return on Capital Employed hit 391.29% in Q4 2025 for Volitionrx, down from 590.4% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 3734.49% in Q2 2025 to a low of 3559.03% in Q1 2023.
  • Median Return on Capital Employed over the past 5 years was 251.97% (2022), compared with a mean of 351.25%.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 401196bps in 2024 and later crashed -397157bps in 2025.
  • Volitionrx's Return on Capital Employed stood at 127.45% in 2021, then plummeted by -627bps to 925.96% in 2022, then surged by 72bps to 256.1% in 2023, then tumbled by -225bps to 831.76% in 2024, then skyrocketed by 147bps to 391.29% in 2025.
  • The last three reported values for Return on Capital Employed were 391.29% (Q4 2025), 590.4% (Q3 2025), and 3734.49% (Q2 2025) per Business Quant data.